These are often mild and short-lived
You dont have to guess your way through this phase, we guide you step by step
What Results Can You Expect With GLP-1 Weight Loss Injections Clinical studies show patients typically lose 15% to 20% of their body weight with consistent use
Comorbid conditions such as type 2 diabetes, hypertension, or sleep apnea may require indefinite GLP-1 continuation for cardiovascular and metabolic protection independent of weight loss goals
As detailed in AARPs coverage guide updated on November 21, 2025, the Medicare Prescription Drug, Improvement, and Modernization Act of 2003 explicitly prohibits Medicare Part D plans from covering medications prescribed primarily for weight loss as part of the standard benefit
Since many people who are candidates for GLP-1s also have risk factors for cardiovascular issues, establishing this baseline is critical